Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  thrombocytopenia
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-19 of 19 for your search:
Start Over
Phase III Study of High-Dose CTX plus GM-CSF with vs without WR-2721 Chemoprotection in Patients with Advanced Malignancies
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9160, CALGB-9160
Phase I/II Study of IL-1A/MITO with Ketoconazole for Metastatic Colorectal and Prostate Carcinomas (Summary Last Modified 08/95)
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CRB-9202, NCI-T94-0090N, T94-0090
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069246, CALGB-10003, NCT00031980
Phase II Study of CDDP/WR-2721 in Patients with Metastatic Breast Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 72
Sponsor: NCI
Protocol IDs: EST-8188
Phase II Pilot Study of a Modified Orange Regimen in the Treatment of Childhood Nonlocalized Nonlymphoblastic Lymphoma
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: CCG-5911
Phase II Randomized Study to Evaluate the Hematopoietic Effect of IL-1A on Granulothrombocytopenia Associated with Hemibody Irradiation
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9206, RTOG-92-06
G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0623, CDR0000574000, NCI-2009-00742, NCT00554463
Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy
Phase: Phase II
Type: Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NYU 10-02429, P30CA016087, NCT01676961
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 09717, CCG-09717, CDR0000066668, NCT00003597
Phase I Trial of WR-2721 with High-Dose CDDP in Patients with non-Small Cell Lung Cancer and Other Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCUM-8816, NCI-T88-0194D, T88-0194
Phase I Trial of CBDCA/WR-2721 in Patients with Advanced Malignancies
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCF-RPC-3144, NCI-T89-0153O, T89-0153
Phase I Study of Doxorubicin with ICRF-187 Cardioprotection plus GM-CSF in Patients with Advanced Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NYU-T89-0049, NCI-T89-0049D, T89-0049
Phase I Trial of High-Dose DOX plus Recombinant GM-CSF plus ADR-529 in Patients with Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-8983, CALGB-8983
Phase I Study of CBDCA/CDDP with Toxicity Attenuation with WR-2721 in Patients with Metastatic Carcinomas
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: LAC-USC-0C903, NCI-T89-0028D, T89-0028
Phase I Study of Methylene Blue for the Treatment of Hypotension in Patients with Advanced Cancer Receiving IL-1A Support for CBDCA
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-9211, NCI-T92-0216N, T92-0216
Phase I Pilot Pharmacokinetic Study of Carboxypeptidase G2 Rescue of High-Dose MTX in Patients with Recurrent Primary CNS Lymphoma
Phase: Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-93040, NCI-T92-0244D, T92-0244
Pilot Study of GM-CSF to Ameliorate Radiation-Related Granulocytopenia in Patients with Lymphoma (Summary Last Modified 01/91)
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-90-C-134, NCI-T90-0015N, T90-0015
Start Over